Summary
The effects of atenolol (2–5 mmol/l), sotalol (1–2 mmol/l) and pamatolol (0.1–1 mmol/l), together with N-tertiary butyl phenoxypropanolamines with o-methyl (D-2T: 50–100 μmol/l) m-methyl (D-3T: 50–100 μmol/l) and p-methyl (D-4T:100–200 μmol/l) group as well as with o,p-methyl groups (D-24T) (50–100 μmol/l) on action potentials (APs) were investigated in isolated guinea-pig papillary muscles. All the drugs in these concentrations produced a concentration-dependent reduction of the maximum upstroke velocity (V max). The reduction ofV max in premature APs induced by stimuli interpolated between the basic driving rate of 0.25, 0.1 or 0.027 Hz decayed exponentially during diastolic intervals. The time constants of these decay processes τ for atenolol, pamatolol and sotalol ranged between 260–541 ms, those for D-3T and D-4T between 655–1,166 ms, and D-2T and D-24T between 1,565–1,931 ms. A drug which provided larger τ values caused the reduction ofV max in a wider range of the frequency. With respect to the aryloxypropanolamine derivatives so far studied (Sada and Ban 1980, 1981 a, b; Sada et al. 1983) fairly good correlations were found as follows: between logn-octanol/water partition coefficient (logP) and ED20 at 0.25 Hz, ED30 at 1 and 4 Hz for 11–14 compounds; between logP and resting block, between molecular weight and A co i.e. the value extrapolated to the time of APD90 of the conditioning response relative to the predrugV max value which may represent a fraction of channels blocked per AP for 100 μmol/l of 20–22 compounds. With respect to 8 compounds with methyl substituents in the benzene ring or amine part the ortho methyl group makes a major contribution to increase the resting block and to increase log τ values.
Similar content being viewed by others
References
Ban T, Sada H, Harada S (1983) Time dependent and independent depression of maximum upstroke velocity of guinea pig ventricular action potentials by β-adrenoceptor blocking agents. J Mol Cell Cardiol (Suppl 1) 15:250
Barrett AM (1977) The pharmacology of atenolol. Postgrad Med J 53:58–64
Bean BP, Cohen CJ, Tsien RW (1982) Block of cardiac sodium channels by tetrodotoxin and lidocaine: sodium current andV max experiments. In: Paes de Carvalho A, Hoffman BF, Lieberman M (eds) Normal and abnormal conduction in the heart. Futura, New York, pp 189–209
Campbell TJ (1983) Importance of physico-chemical properties in determining the kinetics of the effects of Class I antiarrhythmic drugs on maximum rate of depolarization in guinea-pig ventricle. Br J Pharmacol 80:33–40
Carruthers SG (1978) Pamatolol: Phase I evaluation of the pharmacodynamics of a cardioselective beta adrenoceptor blocking drug. Clin Pharmacol Ther 24:168–174
Cohen I, Atwell D, Strichartz G (1981) The dependence of the maximum rate of rise of the action potential upstroke on membrane properties. Proc R Soc Lond B 214:85–98
Colatsky TJ (1980) Voltage clamp measurements of sodium channel properties in rabbit cardiac Purkinje fibres. J Physiol 305: 215–234
Courtney KR (1980) Interval-dependent effects of small antiarrhythmic drugs on excitability of guinea-pig myocardium. J Mol Cell Cardiol 12:1273–1286
Courtney KR (1981) Significance of bicarbonate for antiarrhythmic drug action. J Mol Cell Cardiol 13:1031–1034
Cruickshank JM (1980) The clinical importance of cardioselectivity and lipophilicity in beta blockers. Am Heart J 100:160–178
Free SM, Wilson JW (1964) A mathematical contribution to structure-activity studies. J Med Chem 7:395–399
Frishman W, Silverman R (1979) Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications. Am Heart J 97:119–131
Fujita T, Ban T (1971) Structure-activity study of phenethylamines as substrates of biosynthetic enzymes of sympathetic transmitters. J Med Chem 14:148–152
Hansch C, Leo A (1979) Substituent constants for correlation analysis in chemistry and biology. Wiley-Interscience, New York
Hellenbrecht D, Muller K-F, Grobecker H (1974) Prediction of the non-specific cardiodepressant effects of β-adrenoceptor blocking agents in vitro and in vivo by means of the Hansch analysis. Eur J Pharmacol 29:223–235
Hille B (1977) Local anaesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 69:497–515
Hille B, Courtney K, Dum R (1975) Rate and site of action of local anesthetics in myelinated nerve fibers. Prog Anesthesiol 1:13–24
Hondeghem LM, Katzung BG (1977) Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta 472:373–398
Johansson B (1979) Effects of atenolol, metoprolol, and pamatolol on cardiac and vascular beta-adrenoceptors in the rat. J Cardiovasc Pharmacol 1:287–298
Levy JV (1968) Myocardial and local anesthetic actions of β-adrenergic receptor blocking drugs: relationship to physicochemical properties. Eur J Pharmacol 2:250–257
Rauls DO, Baker JK (1979) Relationship of nonspecific antiarrhythmic and negative inotropic activity with physicochemical parameters of propranolol analogues. J Med Chem 22:81–86
Ritchie JM, Greengard P (1966) On the mode of action of local anesthetics. Ann Rev Pharmacol 6:405–430
Sada H, Ban T (1980) Effects of acebutolol and other structurally related beta adrenergic blockers on transmembrane action potential in guinea-pig papillary muscles. J Pharmacol Exp Ther 215:507–514
Sada H, Ban T (1981a) Effects of various structurally related betaadrenoceptor blocking agents on maximum upstroke velocity of action potential in guinea-pig papillary muscles. Naunyn-Schmiedeberg's Arch Pharmacol 317:245–251
Sada H, Ban T (1981b) Time-independent effects on cardiac action potential upstroke velocity (resting block) and lipid solubility of beta adrenergic blockers. Experientia 37:171–172
Sada H, Harada S, Ban T (1983) Effects of beta-adrenoceptor blocking agents of N-tertiary butyl derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles. Naunyn-Schmiedeberg's Arch Pharmacol 324:50–57
Singh BN, Vaughan Williams EM (1970) A third class of antiarrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol 39:675–687
Singh BN, Nibet HD, Harris EA, Whitlock RML (1975) A comparison of the actions of ICI 66082 and propranolol on cardiac and peripheral β-adrenoceptors. Eur J Pharmacol 34:75–86
Strauss HC, Bigger JT, Hoffman BF (1970) Electrophysiological and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ Res 26:661–678
Trautwein W, McDonald TF (1978) Current-voltage relations in ventricular muscle preparations from different species. Pflügers Arch 374:79–89
Yeh JZ (1980) Blockage of sodium channels by stereoisomers of local anesthetics. Prog Anesthesiol 2:35–44
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ban, T., Sada, S., Takahashi, Y. et al. Effects of para-substituted beta-adrenoceptor blocking agents and methyl-substituted phenoxypropanolamine derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles. Naunyn-Schmiedeberg's Arch. Pharmacol. 329, 77–85 (1985). https://doi.org/10.1007/BF00695196
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00695196